Aimovig 70mg/ml injection pen
Choose delivery option:
Choose from our selected products for you
Shop ProductsAimovig 70mg/ml pre-filled injection pen
Aimovig contains erenumab, a biological monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor involved in migraine signalling. This 70mg/ml pre-filled pen is used for migraine prevention in adults.
What is Aimovig used for?
Aimovig is a preventive treatment for episodic and chronic migraine. It is intended to help reduce migraine frequency, not to provide immediate relief during an ongoing attack. Suitability depends on individual medical assessment.
Product details
- Brand: Aimovig.
- Manufacturer: Amgen.
- Active ingredient: erenumab.
- Strength: 70 mg/ml.
- Presentation: pre-filled injection pen.
- Route: subcutaneous injection.
How it is used
Aimovig is administered by subcutaneous injection according to the prescribed treatment plan. The dose, injection schedule and device technique should follow the instructions for the supplied pen.
Important precautions
Discuss a history of severe constipation, high blood pressure or allergic reactions with the treating doctor. Pregnancy and breastfeeding require individual medical advice.
Possible side effects
Possible side effects include injection-site reactions and constipation. Serious allergic reactions, constipation-related complications and new or worsening high blood pressure can occur. Severe or persistent symptoms require prompt medical attention.
Frequently asked questions
What is the active ingredient?
Aimovig contains erenumab, a CGRP receptor-targeting monoclonal antibody.
Does Aimovig stop an ongoing migraine?
No. It is a preventive medicine, not an acute migraine rescue treatment.
Is this the 140 mg pen?
No. This listing is for the 70mg/ml presentation.
How should the pen be stored?
Follow the temperature limits and handling instructions on the supplied pack and leaflet. Do not assume that storage limits for a different market or presentation apply.
What if a dose is missed?
Follow the missed-dose instructions in the supplied leaflet or ask the treating clinician before adjusting the schedule.
